ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,424Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 2094

$2.05M Total Retail Price of All Prescriptions

Rank: 14 out of 2094

533 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 16,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
NEXIUM 787 761 1 16
ZOLPIDEM TARTRATE 569 518 2 14
ATORVASTATIN CALCIUM 540 523 3 5
CRESTOR 508 487 4 15
DIOVAN 497 486 5 13
LOVAZA 438 424 6 53
BENICAR 392 375 7 108
METOPROLOL SUCCINATE 384 384 8 9
PLAVIX 364 361 9 38
DIOVAN HCT 348 332 10 28
JANUMET 304 284 11 86
EXFORGE HCT 300 300 10 12 195
CLOPIDOGREL 300 297 12 22
NITROGLYCERIN PATCH 295 295 14 101
SIMVASTATIN 277 269 15 1
BYSTOLIC 262 262 16 83
GLIMEPIRIDE 246 243 17 31
ATELVIA 243 236 18 135
DEXILANT 225 212 19 124
MECLIZINE HCL 208 206 20 103
CARVEDILOL 206 193 21 19
METFORMIN HCL 204 189 22 8
DONEPEZIL HCL 200 198 23 20
CYMBALTA 195 181 24 61
LIPITOR 195 193 24 39
LEVOTHYROXINE SODIUM 184 184 26 3
EXELON 184 184 26 111
DICLOFENAC SODIUM 176 169 28 168
OMEPRAZOLE 175 167 29 4
ISOSORBIDE MONONITRATE ER 172 172 30 57
ONGLYZA 171 171 31 134
TRIBENZOR 169 166 32 264
EXFORGE 159 159 33 105
LIDODERM 150 142 34 59
TAMSULOSIN HCL 148 132 35 29
BENICAR HCT 145 145 36 133
JANUVIA 145 143 36 35
AMLODIPINE BESYLATE 144 133 38 2
CLONIDINE HCL 141 128 39 62
IBANDRONATE SODIUM 135 128 40 140
TRAMADOL HCL 129 129 41 33
LOSARTAN POTASSIUM 128 115 42 17
VYTORIN 120 116 43 162
RANITIDINE HCL 117 117 44 80
ZENPEP 107 103 45 359
ATENOLOL 96 95 46 21
LUNESTA 95 95 47 293
PENTOXIFYLLINE 94 94 48 433
CILOSTAZOL 91 91 49 204
PRADAXA 90 90 50 209
TORSEMIDE 86 86 51 118
TRILIPIX 85 82 52 156
BONIVA 81 75 53 256
SPIRIVA 80 61 54 60
ZETIA 80 80 54 79
METFORMIN HCL ER 76 76 56 67
ESCITALOPRAM OXALATE 75 68 57 46
NAMENDA 74 74 58 32
FLUTICASONE PROPIONATE 74 74 58 41
DIGOXIN 73 69 60 51
LEVOXYL 66 66 61 130
ALENDRONATE SODIUM 65 65 62 30
LIVALO 65 65 62 333
NASONEX 64 60 64 194
HYDROCHLOROTHIAZIDE 64 64 64 12
RANEXA 63 63 66 323
MICARDIS 60 56 67 252
ACTONEL 60 58 67 151
FUROSEMIDE 58 58 69 6
VOLTAREN 58 58 69 109
LOSARTAN-HYDROCHLOROTHIAZIDE 58 51 69 52
DOXYCYCLINE HYCLATE 55 48 72 187
HYDROCODONE BIT-IBUPROFEN 53 41 S3 73 279
AMITIZA 52 52 74 239
SYNTHROID 52 52 74 44
CICLOPIROX 51 42 76 315
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.